EMCDDA Home
  • EN
Search

Published: 15 November 2011

Figure 9: Last year prevalence of cocaine use among young adults (15-34) in Europe, Australia, Canada and the USA

Annual report figure

NB:

Data are from the last survey available for each country. The European average prevalence rate was calculated as the average of the national prevalence rates weighted by national population of 15- to 34-year-olds (2007, taken from Eurostat). US and Australian data have been recalculated from original survey results to the age bands 16-34 and 14-39 years, respectively. Data for Australia refer to 2007, data for Canada and the USA to 2009. See Figure GPS-20 in the 2011 statistical bulletin for further information.

Source:

Reitox national focal points.
AIHW (2008), 2007 National drug strategy household survey: detailed findings, Drug statistics series No 22, Australian Institute of Health and Welfare, Canberra.
CADUMS (2010), Canadian alcohol and drug use monitoring survey 2009, Health Canada. Controlled Substances and Tobacco Directorate (available online).
SAMHSA (2010), Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings, Substance Abuse and Mental Health Services Administration, Rockville, MD (available online).

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00

More contact options >>

Page last updated: Friday, 28 October 2011